Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Carbapenem Resistant Enterobacteriaceae

ABSTRACT: Imipenem-Relebactam Susceptibility and Genotypic Characteristics of Carbapenem Resistant Enterobacterales (CRE) Identified during Population-Based Surveillance

PROVIDER: PRJNA748096 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR25010539.fastq.gz	Fastqsanger.gz
	SRR25010540.fastq.gz	Fastqsanger.gz
	SRR25010541.fastq.gz	Fastqsanger.gz
	SRR25010542.fastq.gz	Fastqsanger.gz
	SRR25010543.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 19

Similar Datasets

Pseudomonas aeruginosa

Project description:Imipenem and Imipenem/Relebactam susceptibility in Pseudomonas aeruginosa.

| PRJNA873916 | ENA

Carbapenem-resistant Enterobacterales (CRE)

Project description:Carbapenem-resistant Enterobacterales (CRE) 2009-2019 Raw sequence reads

| PRJNA1102395 | ENA

The impact of heat stress on imipenem susceptibility in imipenem resistant NTHi

Project description:The purpose of the present study was to investigate the impact of heat stress for increasing imipenem susceptibility in imipenem resistant nontypeable Haemophilus influenzae (NTHi).

2019-01-15 | E-MTAB-6237 | biostudies-arrayexpress

Project description:Imipenem-relebactam resistance in KPC-producing Klebsiella pneumoniae

| PRJNA869900 | ENA

Project description:Imipenem/relebactam Challenge Set Genome sequencing and assembly

| PRJNA523732 | ENA

Enterobacteriaceae

Project description:Minnesota CRE project

| PRJNA272863 | ENA

Project description:Resistance to imipenem-relebactam in KPC-producing Klebsiella pneumoniae

| PRJNA809903 | ENA

Carbapenem reistant Enterobacteriaceae

Project description:Carbapenem reistant Enterobacteriaceae isolated from patients during a surveillance study

| PRJEB27539 | ENA

Carbapenem-resistant Enterobacteriaceae

Project description:Whole genome and metagenomic sequencing of isolates and samples from a patient who tested positive for carbapenem-resistant organisms following stem cell transplant Genome sequencing and assembly

| PRJNA513350 | ENA

Carbapenem-nonsusceptible Enterobacteriaceae in Taiwan.

Project description:A total of 1135 carbapenem-resistant (nonsusceptible) Enterobacteriaceae (CRE) isolates were recovered between November 2010 and July 2012 (517 from 2010-2011 and 618 from 2012) from 4 hospitals in Taiwan. Carbapenemase-producing Enterobacteriaceae (CPE) comprised 5.0% (57 isolates), including 17 KPC-2 (16 Klebsiella pneumoniae and 1 Escherichia coli), 1 NDM-1 (K. oxytoca), 37 IMP-8 (26 Enterobacter cloacae, 4 Citrobacter freundii, 4 Raoultella planticola, 1 K. pneumoniae, 1 E. coli and 1 K. oxytoca), and 2 VIM-1 (1 E. cloacae, 1 E. coli). The KPC-2-positive K. pneumoniae were highly clonal even in isolates from different hospitals, and all were ST11. IMP-8 positive E. cloacae from the same hospitals showed higher similarity in PFGE pattern than those from different hospitals. A total of 518 CRE isolates (45.6%) were positive for blaESBL, while 704 (62.0%) isolates were blaAmpC-positive, 382 (33.6% overall) of which carried both blaESBL and blaAmpC. CTX-M (414, 80.0%) was the most common blaESBL, while DHA (497, 70.6%) and CMY (157, 22.3%) were the most common blaAmpC. Co-carriage of blaESBL and blaAmpC was detected in 31 (54.4%) and 15 (26.3%) of the 57 CPE, respectively. KPC-2 was the most common carbapenemase detected in K. pneumoniae (2.8%), while IMP-8 was the most common in E. cloacae (9.7%). All KPC-2-positive CRE were resistant to all three tested carbapenems. However, fourteen of the 37 IMP-8-positive CRE were susceptible to both imipenem and meropenem in vitro. Intra- and inter-hospital spread of KPC-2-producing K. pneumoniae and IMP-8-producing E. cloacae likely occurred. Although the prevalence of CPE is still low, careful monitoring is urgently needed. Non-susceptibility to ertapenem might need to be considered as one criterion of definition for CRE in areas where IMP type carbapenemase is prevalent.

| S-EPMC4368706 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data